Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1974 May;5(5):439–443. doi: 10.1128/aac.5.5.439

In Vitro Susceptibility of Shigella Strains to Trimethoprim and Sulfamethoxazole

Raul C Rudoy a, John D Nelson a, Kenneth C Haltalin a,1
PMCID: PMC428990  PMID: 4618458

Abstract

Trimethoprim and sulfamethoxazole were tested alone and in combination against 227 recently isolated Shigella strains. Variations in medium constituents and inoculum size were used to determine the optimal testing conditions. The plate dilution method with addition of 5% lysed horse blood to the susceptibility test medium and an inoculum size of 102 organisms was found to provide satisfactory results. All 227 strains were inhibited by low concentrations of trimethoprim, and all were susceptible to the combination of 0.06 μg of trimethoprim per ml and 1.25 μg of sulfamethoxazole per ml. Sixteen percent of these strains were resistant to ampicillin, 33% to tetracycline, 15% to chloramphenicol, and 27% to cephalothin. Based on these in vitro observations, trimethoprim and sulfamethoxazole appear worth evaluating for treatment of shigellosis due to multiply antibiotic-resistant strains.

Full text

PDF
439

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bauer A. W., Kirby W. M., Sherris J. C., Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966 Apr;45(4):493–496. [PubMed] [Google Scholar]
  2. Bushby S. R., Hitchings G. H. Trimethoprim, a sulphonamide potentiator. Br J Pharmacol Chemother. 1968 May;33(1):72–90. doi: 10.1111/j.1476-5381.1968.tb00475.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bushby S. R. Trimethoprim-sulfamethoxazole: in vitro microbiological aspects. J Infect Dis. 1973 Nov;128(Suppl):442–p. doi: 10.1093/infdis/128.supplement_3.s442. [DOI] [PubMed] [Google Scholar]
  4. DONALD W. D. THE IN VITRO SENSITIVITIES OF 70 STRAINS OF SHIGELLA. Pediatrics. 1964 Nov;34:705–707. [PubMed] [Google Scholar]
  5. Franzén C., Lidin-Janson G., Nygren B. Trimethoprim-sulphamethoxazole in enteric infections. Scand J Infect Dis. 1972;4(3):231–240. doi: 10.3109/inf.1972.4.issue-3.10. [DOI] [PubMed] [Google Scholar]
  6. HALTALIN K. C., NELSON J. D. IN VITRO SUSCEPTIBILITY OF SHIGELLAE TO SODIUM SULFADIAZINE AND TO EIGHT ANTIBIOTICS. JAMA. 1965 Aug 30;193:705–710. doi: 10.1001/jama.1965.03090090011002. [DOI] [PubMed] [Google Scholar]
  7. Haltalin K. C. Ampicillin and shigellosis. Am J Dis Child. 1973 Mar;125(3):458–458. doi: 10.1001/archpedi.1973.04160030108023. [DOI] [PubMed] [Google Scholar]
  8. Harbin R. L., Ratner H. B., Schaffner W. Topics in infectious diseases. Increasing resistance of Shigellae to antibiotics. J Tenn Med Assoc. 1972 Nov;65(11):999–1000. [PubMed] [Google Scholar]
  9. Jarvis K. J., Scrimgeour G. In-vitro sensitivity of Shigella sonnei to trimethoprim and sulphamethoxazole. J Med Microbiol. 1970 Aug;3(3):554–557. doi: 10.1099/00222615-3-3-554. [DOI] [PubMed] [Google Scholar]
  10. Lexomboon U., Mansuwan P., Duangmani C., Benjadol P., M'cMinn M. T. Clinical evaluation of co-trimoxazole and furazolidone in treatment of shigellosis in children. Br Med J. 1972 Jul 1;3(5817):23–26. doi: 10.1136/bmj.3.5817.23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Ross S., Controni G., Khan W. Resistance of shigellae to ampicillin and other antibiotics. Its clinical and epidemiological implications. JAMA. 1972 Jul 3;221(1):45–47. [PubMed] [Google Scholar]
  12. Schwartz D. E., Ziegler W. H. Assay and pharmacokinetics of trimethoprim in man and animals. Postgrad Med J. 1969 Nov;45(Suppl):32–37. [PubMed] [Google Scholar]
  13. Waterworth P. M. Practical aspects of testing sensitivity to trimethoprim and sulphonamide. Postgrad Med J. 1969 Nov;45(Suppl):21–29. [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES